Mannose corrects altered N-glycosylation in carbohydrate-deficient glycoprotein syndrome fibroblasts.
Open accessThe DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Abstract
Type I carbohydrate-deficient glycoprotein syndrome (CDGS) patients fail to add entire N-linked oligosaccharide chains to some serum glycoproteins.Here we show that four CDGS fibroblast cell lines have two related glycosylation abnormalities.First, they incorporate 3-10-fold less [ 3 H] mannose into proteins, and, second, the size of the lipid-linked oligosaccharide precursor (LLO) is much smaller than in controls.Addition of exogenous mannose, but not glucose, to these CDGS cells corrects both the lowered [ 3 H]mannose incorporation and the size of LLO.These corrections are not permanent, and the defects immediately reappear when mannose is removed.To explore further the basis of mannose correction, we analyzed the amount of 3 H-labeled LLO intermediates.Except for dolichol-P-mannose, other precursors, including mannose, mannose-6-phosphate, mannose-1-phosphate, and GDP-mannose, all showed a 3-10fold decrease in CDGS cells.Thus, there are no obvious lesions in the intracellular conversion of mannose into LLO, and, once inside the cell, [ 3 H]mannose appeared to be metabolized normally.Initial velocities of [ 3 H] mannose uptake were two-to threefold less in CDGS cells compared with controls, and this slower transport may partially explain the reduced [ 3 H]mannose incorporation in CDGS cells.Since we previously showed that the enzymes converting glucose to mannose-6-phosphate appear to be normal, our results suggest that cells may acquire or generate mannose in other ways.Although we have not identified the primary defect in CDGS, these studies show that intracellular mannose is limited and that some patients might benefit from including mannose in their regular diets.( J. Clin.Invest.1996.97:1478-1487.)Key words: glycosylation • lipidlinked oligosaccharide • glycoprotein • hexose transporter • CDG syndrome Methods Materials.Most of the materials were obtained from Sigma Chemical Co.(St.Louis, MO), except for the following: concanavalin A (Con A)-Sepharose (Pharmacia Fine Chemicals, Piscataway, NJ), ␣ -MEM (GIBCO BRL, Baltimore, MD), FBS (Hyclone Laboratories, Logan, UT), Micropak AX-5 HPLC column (Varian Instruments, Walnut Creek, CA), and microspin filters (Lida Manufacturing Corp., Kenosha, WI).Radiolabels.2-[ 3 H]Mannose (15 Ci/mmol), 2-deoxy[1,2-3 H(N)]glucose (40 Ci/mmol), and [ 35 S]methionine (1,217 Ci/mmol) were obtained from American Radiolabeled Chemicals, Inc. (St. Louis, MO).Cell lines.The CDGS and control cell lines were all obtained from Dr. Neil Buist (Department of Pediatrics, Oregon Health Sciences University, Portland, OR).CDGS 1 and 2, our designation, are patients from the same family (samples F27467 and F27468) described in our previous study (13).CDGS cell lines 3 and 4 are patients from another family (samples F20660 and F02661, coded by Dr. N. Buist).All these patients are diagnosed as type I CDGS based on the clinical and biochemical (transferrin pattern) analyses.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
ASSEMBLY OF ASPARAGINE-LINKED OLIGOSACCHARIDES
Kornfeld, R., & Kornfeld, S. (1985) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.54.070185.003215 · Cited by 4,906
Facilitated diffusion of glucose
Carruthers, A. (1990) · Physiological Reviews · doi:10.1152/physrev.1990.70.4.1135 · Cited by 361
Gould, G. W., Thomas, H. M., Jess, T. J., & Bell, G. I. (1991) · Biochemistry · doi:10.1021/bi00235a004 · Cited by 303
Jaeken, J., van Eijk, H. G., van der Heul, C., Corbeel, L., Eeckels, R., & Eggermont, E. (1984) · Clinica Chimica Acta · doi:10.1016/0009-8981(84)90059-7 · Cited by 280 · cited 1×
“All patients show altered isoelectric focusing patterns of multiple serum glycoproteins that result from undersialylation of their N-linked oligosaccharides (3, 4).”
BackgroundEnvironmental Effects on Protein Glycosylation
Goochee, C. F., & Monica, T. (1990) · Nature Biotechnology · doi:10.1038/nbt0590-421 · Cited by 247
Chapman, A., Fujimoto, K., & Kornfeld, S. (1980) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)85510-2 · Cited by 233
Assembly of Asparagine-Linked Oligosaccharides
Kornfeld, R. (1985) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.54.1.631 · Cited by 215
Jaeken, J., Schachter, H., Carchon, H., De Cock, P., Coddeville, B., & Spik, G. (1994) · Archives of Disease in Childhood · doi:10.1136/adc.71.2.123 · Cited by 193
The role of N-glycosylation of GLUT1 for glucose transport activity.
Asano, T., Katagiri, H., Takata, K., Lin, J. L., Ishihara, H., Inukai, K., Tsukuda, K., Kikuchi, M., Hirano, H., & Yazaki, Y. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)54276-9 · Cited by 187
Jaeken, J., Stibler, H., & Hagberg, B. A. (1991) · PubMed · Cited by 187
Cited by
Varki, A. (2017) · Glycobiology · doi:10.1093/glycob/cww086 · Cited by 2,635
Niehues, R., Hasilik, M., Alton, G., Körner, C., Schiebe-Sukumar, M., Koch, H. G., Zimmer, K. P., Wu, R., Harms, E., Reiter, K., et al. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2350 · Cited by 422
“Based on studies showing that mannose could correct abnormal glycosylation in CDGS type Ia fibroblasts (15), mannose therapy was initiated and followed up for 11 mo.”
BackgroundSelf-citationMarquardt, T., & Denecke, J. (2003) · European Journal of Pediatrics · doi:10.1007/s00431-002-1136-0 · Cited by 290
Altered glycan structures: the molecular basis of congenital disorders of glycosylation
Freeze, H. H., & Aebi, M. (2005) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2005.08.010 · Cited by 250
Self-citationCongenital disorders of glycosylation
Chang, I. J., He, M., & Lam, C. T. (2018) · Annals of Translational Medicine · doi:10.21037/atm.2018.10.45 · Cited by 235
Metadata
- Authors
- Panneerselvam, K., & Freeze, H. H.
- Affiliations
- Sanford Burnham Prebys Medical Discovery Institute (US)
- Oregon Health & Science University (US)
- ORCID
- Freeze, H H
- Venue
- Journal of Clinical Investigation
- Published
- 1996-03-15
- Volume
- 97
- Issue
- 6
- Pages
- 1478-1487
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC507208
- OpenAlex
- W2015514724
- Cited by
- 146
- References
- 57
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 2 · 2023: 3 · 2022: 1 · 2021: 5 · 2020: 4 · 2019: 6 · 2018: 9 · 2017: 2 · 2016: 5 · 2015: 1 · 2014: 1 · 2013: 1 · 2012: 5
- FWCI
- 4.42
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Public Health Service (R01 49096)
- National Institute of General Medical Sciences
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Glycosylation and Glycoproteins Research
- Health Sciences › Medicine › Genetics (clinical) › Lysosomal Storage Disorders Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Glycogen Storage Diseases and Myoclonus
- Keywords
- congenital disorders of glycosylation, N-glycosylation, mannose, lipid-linked oligosaccharides, mannose-6-phosphate, mannose-1-phosphate, GDP-mannose, hexose transporters, fibroblasts, glycoprotein synthesis, congenital disorders
- MeSH terms
- Cell Line, Fibroblasts, Glycosylation, Humans, Mannose, Oligosaccharides, Congenital Disorders of Glycosylation, Lipid Metabolism
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Mannose corrects altered N-glycosylation in carbohydrate-deficient glycoprotein syndrome fibroblasts. https://app.cochat.ai/papers/10.1172/jci118570
- The paper
- Panneerselvam, K., & Freeze, H. H. (1996). Mannose corrects altered N-glycosylation in carbohydrate-deficient glycoprotein syndrome fibroblasts. Journal of Clinical Investigation. https://doi.org/10.1172/jci118570
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.